These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 21308698)
1. Quercetin inhibits invasion, migration and signalling molecules involved in cell survival and proliferation of prostate cancer cell line (PC-3). Senthilkumar K; Arunkumar R; Elumalai P; Sharmila G; Gunadharini DN; Banudevi S; Krishnamoorthy G; Benson CS; Arunakaran J Cell Biochem Funct; 2011 Mar; 29(2):87-95. PubMed ID: 21308698 [TBL] [Abstract][Full Text] [Related]
2. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling. Mamoune A; Kassis J; Kharait S; Kloeker S; Manos E; Jones DA; Wells A Exp Cell Res; 2004 Sep; 299(1):91-100. PubMed ID: 15302576 [TBL] [Abstract][Full Text] [Related]
3. Aspirin inhibits highly invasive prostate cancer cells. Lloyd FP; Slivova V; Valachovicova T; Sliva D Int J Oncol; 2003 Nov; 23(5):1277-83. PubMed ID: 14532966 [TBL] [Abstract][Full Text] [Related]
4. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor. Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628 [TBL] [Abstract][Full Text] [Related]
5. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling. Xue A; Xue M; Jackson C; Smith RC Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression. Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015 [TBL] [Abstract][Full Text] [Related]
7. Saposin C stimulates growth and invasion, activates p42/44 and SAPK/JNK signaling pathways of MAPK and upregulates uPA/uPAR expression in prostate cancer and stromal cells. Koochekpour S; Sartor O; Hiraiwa M; Lee TJ; Rayford W; Remmel N; Sandhoff K; Minokadeh A; Patten DY Asian J Androl; 2005 Jun; 7(2):147-58. PubMed ID: 15897971 [TBL] [Abstract][Full Text] [Related]
8. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice. Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945 [TBL] [Abstract][Full Text] [Related]
9. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R; Schaaf A Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473 [TBL] [Abstract][Full Text] [Related]
10. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system. Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645 [TBL] [Abstract][Full Text] [Related]
11. Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling. Kwon GT; Cho HJ; Chung WY; Park KK; Moon A; Park JH J Nutr Biochem; 2009 Sep; 20(9):663-76. PubMed ID: 18824345 [TBL] [Abstract][Full Text] [Related]
12. EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor. Henic E; Sixt M; Hansson S; Høyer-Hansen G; Casslén B Gynecol Oncol; 2006 Apr; 101(1):28-39. PubMed ID: 16263158 [TBL] [Abstract][Full Text] [Related]
13. Maslinic acid inhibits the metastatic capacity of DU145 human prostate cancer cells: possible mediation via hypoxia-inducible factor-1α signalling. Park SY; Nho CW; Kwon DY; Kang YH; Lee KW; Park JH Br J Nutr; 2013 Jan; 109(2):210-22. PubMed ID: 22716951 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of uPA/uPAR inhibits intermittent hypoxia-induced epithelial-mesenchymal transition (EMT) in DAOY and D283 medulloblastoma cells. Gupta R; Chetty C; Bhoopathi P; Lakka S; Mohanam S; Rao JS; Dinh DE Int J Oncol; 2011 Mar; 38(3):733-44. PubMed ID: 21181094 [TBL] [Abstract][Full Text] [Related]
15. CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer. Xie C; Jiang XH; Zhang JT; Sun TT; Dong JD; Sanders AJ; Diao RY; Wang Y; Fok KL; Tsang LL; Yu MK; Zhang XH; Chung YW; Ye L; Zhao MY; Guo JH; Xiao ZJ; Lan HY; Ng CF; Lau KM; Cai ZM; Jiang WG; Chan HC Oncogene; 2013 May; 32(18):2282-91, 2291.e1-7. PubMed ID: 22797075 [TBL] [Abstract][Full Text] [Related]
16. EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells. Baek MK; Kim MH; Jang HJ; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD Oncol Rep; 2008 Dec; 20(6):1569-75. PubMed ID: 19020743 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of epidermal growth factor-induced invasion by dexamethasone and AP-1 decoy in human squamous cell carcinoma cell lines. Shiratsuchi T; Ishibashi H; Shirasuna K J Cell Physiol; 2002 Dec; 193(3):340-8. PubMed ID: 12384986 [TBL] [Abstract][Full Text] [Related]
18. [Epidermal growth factor-mediated NF-kappaB activation promotes uPA expression and invasiveness in pancreatic cancer cells]. Zhang H; Liu XF; Li YJ; Zhou JP; Kong FM; Dong M Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):909-12. PubMed ID: 18478929 [TBL] [Abstract][Full Text] [Related]
20. Quercetin Has Antimetastatic Effects on Gastric Cancer Cells via the Interruption of uPA/uPAR Function by Modulating NF-κb, PKC-δ, ERK1/2, and AMPKα. Li H; Chen C Integr Cancer Ther; 2018 Jun; 17(2):511-523. PubMed ID: 28627240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]